Khon Kaen Hospital to open first breast cancer centre in Isan Wacoal helps raise funds for medical equipment for integrated treatment

Food and Healthcare Press Releases Tuesday October 31, 2017 17:20
Bangkok--31 Oct--DC Consultants and Marketing Communications

Unlike the residents of Bangkok which has been the centre of progress in all aspects including medicine, many people in the provinces are unable to access fully-equipped medical facilities for effective, integrated treatment of illnesses. This is the case especially with breast cancer, now the most common cancer in Thai women.

To narrow the health divide between people in the capital and the provinces, a fundraising campaign has been organised to establish the first breast cancer centre in the north-eastern region at Khon Kaen Hospital. The campaign is headed by Prof Dr Supakorn Rojananin, Chairman of The Surgeons, for All and President of the International College of Surgeons, Thailand Section, under the Royal Patronage of His Majesty the King, who has been mustering support from the public and private sectors in the hope of distributing advanced medical services to other regions of Thailand for the people's

"We want Khon Kaen to be the first landmark in our success," Dr Supakorn said. "It is the third most populated province in the North-East but it has great potential for public health development, particularly in the field of breast cancer prevention led by Khon Kaen Hospital. The Hospital has received admirable cooperation from the public and private sectors as well as from local people and it has been internationally acclaimed as amodel medical institution for breast cancer prevention and treatment in the north-eastern region. Therefore, our fundraising campaign has been launched to create a more systematic specialised centre here. After a long time and continuous effort, the first one-stop breast cancer centre in the North-East is soon to be completed and we expect it to be opened next year so that the north-eastern residents will no longer need to go to Bangkok to receive breast cancer-related examination and treatment."

Although the centre is nearing completion, additional funding is still needed to acquire some medical equipment. The campaign has been supported by several private organisations, including ICC International Plc, distributor of Wacoal lingerie products; and its partner Thai Wacoal Plc, which together donated 15 million baht on behalf of their "Wacoal Pink Ribbon" breast cancer awareness campaign for the purchase of mammogram and breast ultrasound machines for the centre.

"We intend to make it an integrated centre for breast cancer-related treatment and education, with tasks ranging from primary prevention – educating the surrounding communities on the disease and health care – to treatment of terminal patients," Dr Supakorn added. "We have worked closely with the general public, sending out teams to educate people on how to identify signs of breast cancer, how to perform breast self-exam, and how to avoid risk factors, while encouraging north-eastern women of all ages at risk to receive regular breast checks." "Our goal is to elevate Khon Kaen Hospital to the centre of excellence in breast cancer treatment in the North-East. This will not only help establish Thailand as the leader in breast cancer treatment and prevention in South-East Asia, but our country will be an example of medical progress in this field for our neighbouring countries," he said.

If the development of the breast cancer centre at Khon Kaen Hospital is successful, a similar centre will be created in the northern region through a collaboration between Chiangrai Prachanukroh Hospital and Mae Fah Luang University for the benefits and well-being of the people in that region.

The general public interested in donating for the purchase of medical equipment for the breast cancer centre at Khon Kaen Hospital may call 0 2716 5957 for more information.

Latest Press Release

Merck and Pfizer Provide Update on Phase III JAVELIN Lung 200 Trial of Avelumab Monotherapy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced results from the Phase III JAVELIN Lung 200 trial comparing avelumab* to docetaxel in patients with unresectable, recurrent or metastatic non-small cell lung cancer (NSCLC) whose disease progressed after...

PharmaMar Licenses Fully Synthetic Marine-derived Payloads to Seattle Genetics for Use in Drug Conjugates

PharmaMar (MCE: PHM) has announced today the signing of an exclusive licensing agreement with Seattle Genetics Inc. (SGEN: NASDAQ GS) under which Seattle Genetics receives exclusive worldwide rights to certain PharmaMar proprietary molecules for the...

After multiple failed procedures at other medical institutions, Colorado man successfully treated for Atrial Fibrillation at Texas Cardiac Arrhythmia Institute at St. David#s Medical Center

"I was thinking I was on top of the world," Wiseman said. "I was keeping myself in shape. I was taking care of myself mentally and physically. My relationship was solid." Then, during a routine medical exam while serving in the military in California,...

World#s Leading Health Organizations Release Third Edition of Widely Used Resource on Family Planning

Global Handbook Gives Health-Care Providers Accurate and Practical Guidance for Counseling Clients Family planning is considered a development "best buy" and a life-saving intervention for millions of women and girls. Crucial to the success of family...

ไฟเซอร์ ประเทศไทย สนับสนุนงานประชุมวิชาการด้านโรคมะเร็ง

แผนกมะเร็งวิทยาของบริษัท ไฟเซอร์ (ประเทศไทย) จำกัด (Pfizer Oncology) ให้การสนับสนุนการจัดงานประชุมวิชาการ 'The 5th Ramathibodi-Mayo Clinic Joint Conference: Best Practice in Oncology 2018' ช่วง Lunch Symposium' ในหัวข้อ Continuum of care for ALK positive...

Related Topics